Skip to content
Abierto

Presolicitation

Transcriptomics study – RNA-seq in Liver Spheroids Phase One

75N95024Q00452

National Institutes of Health, National Institutes of Health Nida. Biological Product (except Diagnostic) Manufacturing.

Awarded

Insphero, Inc.

$96,829.63 obligated so far on USAspending

Description

As published on SAM.gov.

PURSUANT TO FAR Subpart 5.2—Synopses of Proposed Contract Actions, THIS IS A PRE-SOLICITATION NOTICE OF A PROPOSED CONTRACT TO ACTION. THIS IS A PRE-SOLICITATION NON-COMPETITIVE NOTICE OF INTENT TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).

The National Center for Advancing Translational Sciences (NCATS) at the National National Insitutes of Health (NIH) intends to negotiate and award to InSphero INC, Tech Place, 74 Orion Street, Brunswick, ME, 04011, a purchase order for a Transcriptomics study – RNA-seq in Liver Spheroids Phase One. The essential characteristics of this study that limit the availability to a sole source is that this project is a continuation of a work currently ongoing at InSphero and data consistency is necessary.

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 325414 – Biological Product (except Diagnostic) Manufacturing.

Number of Employees: 1,250. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses of the Federal acquisition Requlation (FAR) currently in effect at https://www.acquisition.gov/ STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures.

DESCRIPTION OF REQUIREMENT Project Description See Attachment 1 – SOW Purpose and Objectives The purpose of this requirement is to procure a Transcriptomics study – RNA-seq in Liver Spheroids Phase One. CLOSING STATEMENT This synopsis is not a request for competitive proposals, however, interested parties may submit a capability statement for consideration. Responses to this Notice must include clear and convincing evidence of the offeror’s capability of fulfilling the requirement.

In addition the Unique Entity Identifier (UEI), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.

The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by 09:00 AM EDT July 25th, 2024. Responses must be emailed to the Contracting Officer at patricia.dasilva@nih.gov and reference the Notice ID 75N95024Q00452.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
FCCCVSMNHGJ6
CAGE
7WFG6
Vendor location
Brunswick, ME
Contract
75N95024P00513, purchase order
Obligated
$96,829.63
Actions
1 between August 27, 2024 and August 27, 2024
Competition
Not Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Transcriptomics Study RNA-SEQ in Liver Spheroids Phase One
Match
solicitation number 75N95024Q00452 equals the FPDS solicitation identifier; same awarding office 75N950 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. July 18, 2024

    Presolicitation

    Due July 25, 2024 at 9:00 AM EDT. SAM.gov, notice 5dfdfc95fff3492c92adab75a4a9b5d2

Points of contact